BRIEF published on 03/04/2026 at 22:35, 14 days 13 hours ago DBV Technologies will participate in investor conferences in March Investor Conferences Biopharmaceutical DBV Technologies March 2026 Citizens Life Sciences
BRIEF published on 03/04/2026 at 22:35, 14 days 13 hours ago DBV Technologies Announces Participation in March Investor Conferences Investor Conferences Biopharmaceutical DBV Technologies Food Allergies VIASKIN Patch
PRESS RELEASE published on 03/04/2026 at 22:30, 14 days 13 hours ago DBV Technologies to Participate in Upcoming March Investor Conferences DBV Technologies to participate in upcoming investor conferences to present its late-stage biopharmaceutical developments for food allergies. Company uses proprietary VIASKIN patch technology for treatment Investor Conferences Biopharmaceutical DBV Technologies Food Allergies VIASKIN Patch
BRIEF published on 03/03/2026 at 22:35, 15 days 13 hours ago DBV Technologies: Update on voting rights and shares Euronext Paris Share Capital Voting Rights Financial Regulations DBV Technologies
BRIEF published on 03/03/2026 at 22:35, 15 days 13 hours ago DBV Technologies: February 2026 Voting Rights and Shares Update Voting Rights Shares DBV Technologies NYSE Euronext Paris February 2026
PRESS RELEASE published on 03/03/2026 at 22:30, 15 days 13 hours ago Information Regarding the Total Number of Voting Rights and Total Number of Shares of the Company as of February 28, 2026 Important update on total voting rights and shares as of February 28, 2026 for NYSE Euronext Paris. Total gross voting rights: 278,352,082 Shares Total Voting Rights Regulations NYSE Euronext Paris February 28 2026
BRIEF published on 03/02/2026 at 15:53, 16 days 20 hours ago JP Morgan's investment in DBV Technologies reaches new thresholds Crossing Thresholds Equity Swaps Shares And Voting Rights DBV Technologies JP Morgan
BRIEF published on 02/28/2026 at 20:30, 18 days 15 hours ago DBV Technologies reveals promising new results for VIASKIN Peanut Clinical Study Immunotherapy DBV Technologies Food Allergies Viaskin Peanut
BRIEF published on 02/28/2026 at 20:30, 18 days 15 hours ago DBV Technologies Unveils Promising Phase 3 VITESSE Study Results at AAAAI 2026 DBV Technologies Phase 3 Results Viaskin Peanut Patch Peanut Allergy Treatment VITESSE Study
PRESS RELEASE published on 02/28/2026 at 20:25, 18 days 15 hours ago DBV Technologies Highlights Additional Data from Successful Phase 3 VITESSE Study at the AAAAI 2026 Annual Meeting DBV Technologies presents successful Phase 3 VITESSE study data at AAAAI Annual Meeting, highlighting VIASKIN Peanut Patch efficacy in treating peanut-allergic children DBV Technologies Food Allergies Viaskin Peanut Patch Phase 3 VITESSE Study AAAAI Annual Meeting
Published on 03/19/2026 at 12:00, 13 minutes ago Galway Metals Intersects 8.6 g/t Gold Over 15.0m Including 110.0 g/t Over 1.0m at Southwest Deposit
Published on 03/19/2026 at 12:00, 13 minutes ago Gamma Resources Announces Debt Settlement and Insider Warrant Exercises
Published on 03/19/2026 at 12:00, 13 minutes ago Prince Silver Delivers Further Strong Drill Results, Highlighted by 7.62 Metres of 230 G/T Silver, 10.78% Manganese, 1.87% Lead, 2.54% Zinc and 0.58 G/T Gold
Published on 03/19/2026 at 12:00, 13 minutes ago Athena Gold Provides Exploration Update From Excelsior Springs, Nevada
Published on 03/19/2026 at 12:00, 13 minutes ago Aclara Inaugurates Rare Earth Separation Pilot Plant in Virginia Tech to Advance U.S. Supply of Heavy Rare Earths
Published on 03/19/2026 at 12:05, 8 minutes ago CD&R Expands Climate Leadership Program to Europe with Imperial College Business School and Extends Columbia University Partnership in the U.S. for Second Year
Published on 03/19/2026 at 12:00, 13 minutes ago PT Danantara Investment Management opens DPT registration for PSEL partners
Published on 03/19/2026 at 11:18, 55 minutes ago ABB Ltd: ABB share buybacks - March 12, 2026 - March 18, 2026
Published on 03/19/2026 at 08:45, 3 hours 28 minutes ago Deezer and Sonos renew and expand long-term collaboration
Published on 03/19/2026 at 07:00, 5 hours 13 minutes ago bioMérieux Receives IVDR CE‑Marking for Two BIOFIRE® SPOTFIRE® Panels to Strengthen Near‑Patient Respiratory and Sore Throat Diagnostics Across Europe
Published on 03/19/2026 at 07:00, 5 hours 13 minutes ago 2025 Annual results and new strategic signature
Published on 03/18/2026 at 19:41, 16 hours 32 minutes ago Covivio - Conditions of availability of the 2025 Universal Registration Document
Published on 03/18/2026 at 18:00, 18 hours 13 minutes ago Deezer achieves profitability in FY25 as strategy delivers tangible results
